CN116887815A - 难吸收性药物的吸收性得到改善的组合物 - Google Patents

难吸收性药物的吸收性得到改善的组合物 Download PDF

Info

Publication number
CN116887815A
CN116887815A CN202280014688.1A CN202280014688A CN116887815A CN 116887815 A CN116887815 A CN 116887815A CN 202280014688 A CN202280014688 A CN 202280014688A CN 116887815 A CN116887815 A CN 116887815A
Authority
CN
China
Prior art keywords
drug
acid
ionic liquid
composition
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280014688.1A
Other languages
English (en)
Chinese (zh)
Inventor
石田龙弘
辰巳昇
中江崇
三轮泰司
滨本英利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedRx Co Ltd
Original Assignee
MedRx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedRx Co Ltd filed Critical MedRx Co Ltd
Publication of CN116887815A publication Critical patent/CN116887815A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202280014688.1A 2021-02-12 2022-02-10 难吸收性药物的吸收性得到改善的组合物 Pending CN116887815A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021021288 2021-02-12
JP2021-021288 2021-02-12
PCT/JP2022/005412 WO2022173006A1 (ja) 2021-02-12 2022-02-10 難吸収性薬物の吸収性が改善された組成物

Publications (1)

Publication Number Publication Date
CN116887815A true CN116887815A (zh) 2023-10-13

Family

ID=82838345

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280014688.1A Pending CN116887815A (zh) 2021-02-12 2022-02-10 难吸收性药物的吸收性得到改善的组合物

Country Status (5)

Country Link
US (1) US20240108578A1 (https=)
EP (1) EP4292583A4 (https=)
JP (1) JPWO2022173006A1 (https=)
CN (1) CN116887815A (https=)
WO (1) WO2022173006A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6743771B2 (en) * 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
JP5117732B2 (ja) * 2007-01-29 2013-01-16 株式会社 メドレックス 外用剤用の低刺激性溶解助剤
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
CN102046208B (zh) * 2008-03-28 2014-07-02 安琪士摩奇株式会社 包含转录因子诱饵作为活性成分的用于外部应用的组合物
JP5681883B2 (ja) * 2009-03-27 2015-03-11 株式会社 メドレックス 核酸を有効成分とする外用剤組成物
CN102363633B (zh) * 2011-11-16 2013-11-20 天津拓飞生物科技有限公司 胰高血糖素样肽-1突变体多肽及其制备方法、药物组合物和其应用
HUE045479T2 (hu) * 2012-06-20 2019-12-30 Medrx Co Ltd Tapadó preparátum készítmény, amely elõállítható gyógyszerhatóanyag, szerves oldószer, lipofil kenõcsalap és por összekeverésével
WO2014024896A1 (ja) * 2012-08-08 2014-02-13 株式会社メドレックス アゴメラチンを含有する貼付剤組成物
JP5550056B2 (ja) * 2012-09-05 2014-07-16 株式会社 メドレックス 外用剤用の低刺激性溶解助剤
JP5816881B2 (ja) * 2014-05-21 2015-11-18 株式会社 メドレックス 核酸を有効成分とする外用剤組成物
US10475457B2 (en) 2017-07-03 2019-11-12 Qualcomm Incorporated Time-domain inter-channel prediction
US11446253B2 (en) * 2017-11-17 2022-09-20 President And Fellows Of Harvard College Ionic liquids for internal delivery
JP2020169246A (ja) * 2019-04-02 2020-10-15 旭化成株式会社 高分子組成物

Also Published As

Publication number Publication date
WO2022173006A1 (ja) 2022-08-18
US20240108578A1 (en) 2024-04-04
EP4292583A1 (en) 2023-12-20
EP4292583A4 (en) 2024-12-18
JPWO2022173006A1 (https=) 2022-08-18

Similar Documents

Publication Publication Date Title
US8840915B2 (en) Pharmaceutical compositions for sustained release delivery of peptides
JP6258368B2 (ja) 医薬組成物および関連する送達方法
EP0944396B1 (en) Compositions and methods for enhancing intestinal function
US20020061838A1 (en) Peptide pharmaceutical formulations
HK1248607A1 (zh) Ph为7且至少含pi为5．8至8．5之基础胰岛素和取代共聚(氨基酸)的可注射溶液
CN101912600B (zh) 改善胰岛素在溶液中稳定性的方法
US20180271792A1 (en) Oral delivery of physiologically active substances
KR20000010630A (ko) 성장 호르몬, 아미노산, 및 비-이온성 세제를 함유하는 약제학적 조제무류
US20230165964A1 (en) Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
WO2011060922A1 (en) Formulation for hgh and rhigf-1 combination
EP2643009A1 (en) Biodegradable drug delivery composition
US20200222508A1 (en) Glucagon-like peptide 1 (glp-1) receptor agonist compositions
MX2013002045A (es) Composiciones para suministro gastrico de agentes activos.
US11191802B2 (en) Composition for controlled release of therapeutic agents
EP4026566B1 (en) Oral pharmaceutical composition comprising teriparatide and method for preparing same
US20210128598A1 (en) Radiation-Sterilized Biodegradable Drug Delivery Compositions
WO2020208541A1 (en) Composition comprising glp-1 analogue
CN116887815A (zh) 难吸收性药物的吸收性得到改善的组合物
EP1301200A2 (en) Peptide pharmaceutical formulations
US20140187482A1 (en) Insulin preparation
HK40065018A (en) Injectable solution at ph 7 comprising at least basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid
WO2025136880A1 (en) Orally available albenatide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination